Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FiteBac Technology is a biotechnology company focused on the development of persistent antimicrobial technologies for use in dental, medical, and consumer products. The company's core innovation is the K-18 antimicrobial silane molecule, which is designed to be incorporated into materials like dental composites, adhesives, and coatings to provide long-lasting protection against pathogens without leaching. FiteBac’s technology has received FDA clearance for use in various dental applications, including the first antimicrobial cavity cleanser. Beyond dentistry, the company is expanding its platform into skin care, wound care, and medical device coatings to combat the spread of infectious diseases and biofilm formation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FiteBac Technology.